Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

OBJECTIVE: To evaluate the long-term effectiveness and tolerability of adalimumab in the treatment of psoriatic arthritis (PsA). METHODS: Patients with PsA who completed a 24-week, double-blind study of adalimumab versus placebo were eligible to enroll in an open-label extension study and receive ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, P J, Ory, P, Sharp, J T, Ritchlin, C T, Van den Bosch, F, Wellborne, F, Birbara, C, Thomson, G T D, Perdok, R J, Medich, J, Wong, R L, Gladman, D D
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2008
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663711/
https://www.ncbi.nlm.nih.gov/pubmed/18684743
http://dx.doi.org/10.1136/ard.2008.092767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663711/
https://www.ncbi.nlm.nih.gov/pubmed/18684743
http://dx.doi.org/10.1136/ard.2008.092767

Ejemplares similares